Intravenous Access Devices

Intravenous Access Devices Market Outlook

The global intravenous access devices market was valued at approximately USD 25 billion in 2022 and is projected to reach around USD 37 billion by 2035, growing at a robust CAGR of 6.4% during the forecast period. The growth of this market can be attributed to a multitude of factors, including the increasing prevalence of chronic diseases that require long-term intravenous therapy, the rise in surgical procedures, and the ongoing advancements in medical technologies that enhance patient safety and efficacy in drug delivery. Additionally, the growing geriatric population, who often require intravenous access for various medical conditions, plays a significant role in driving market demand. The market is also benefitting from improved healthcare infrastructures and increased hospital expenditures, particularly in emerging economies, which further supports the expansion of this essential medical segment.

Growth Factor of the Market

Several growth factors are significantly influencing the intravenous access devices market. First and foremost, the increasing incidence of diseases such as cancer, diabetes, and cardiovascular disorders is prompting healthcare providers to seek efficient and effective methods for medication administration. This has led to an increased demand for intravenous access devices, as they provide a reliable route for delivering medications, fluids, and blood products. Another factor contributing to market growth is the rapid evolution of medical technologies, which has resulted in the development of advanced intravenous devices designed to enhance patient experiences and outcomes through reduced complications and infections. Moreover, the growing focus on minimally invasive procedures is facilitating the adoption of various catheter types, boosting their utilization in healthcare settings. A burgeoning awareness of patient safety and the prevention of complications related to intravenous access has also prompted healthcare facilities to implement the latest protocols and devices to ensure high standards of care. Additionally, the rise in outpatient procedures and home healthcare services is further propelling the demand for portable and easy-to-use intravenous access devices.

Key Highlights of the Market

• The intravenous access devices market is projected to experience significant growth at a CAGR of 6.4% from 2022 to 2035.
• Increasing prevalence of chronic diseases and geriatric populations are major drivers for market expansion.
• The market is witnessing technological advancements leading to the development of safer, smarter intravenous devices.
• The rise in outpatient and home healthcare services is fostering increased demand for portable intravenous devices.
• Geographically, North America holds a significant share of the market, owing to advanced healthcare infrastructure and high patient awareness.

By Product Type

Peripheral Catheters:

Peripheral catheters are one of the most widely used intravenous access devices, primarily due to their ease of insertion and minimal need for specialized skills. These catheters are predominantly placed in the veins of the arm or hand and are used for short-term therapies, such as delivering medications or fluids. The growth of this segment is largely driven by the increasing number of outpatient procedures and the preference for less invasive options. Furthermore, improvements in catheter design, such as the introduction of safety mechanisms to minimize needlestick injuries, are enhancing their appeal in clinical settings. As hospitals and clinics strive to ensure patient safety, the demand for peripheral catheters is expected to remain robust in the coming years, making it a critical component of the intravenous access devices market.

Central Venous Catheters:

Central venous catheters (CVCs) are essential for patients who require long-term intravenous therapy or have difficult venous access. These devices are inserted into large central veins and are designed for administering medications, fluids, and blood products. The rise in the prevalence of chronic illnesses, such as cancer and renal failure, is significantly boosting the demand for CVCs, as these patients often require prolonged treatment regimens. Moreover, advancements in CVC technologies, including the development of antimicrobial-coated catheters, are fostering their adoption by reducing the risk of infections associated with long-term catheter use. The central venous catheter market is growing rapidly, with healthcare providers increasingly recognizing the importance of proper device selection and management in ensuring optimal patient outcomes.

Integrated/Closed Catheters:

Integrated or closed catheters are designed to minimize the risk of infection by providing a closed system that prevents contamination during medication administration. These devices are particularly advantageous in hospital settings, where infection control is paramount. The growing emphasis on patient safety and the reduction of healthcare-associated infections are driving the adoption of integrated catheters. Furthermore, as hospitals increasingly implement stringent infection control protocols, the demand for closed system catheters is expected to rise. The integrated/closed catheter segment is poised for growth due to its ability to enhance patient safety while also contributing to improved clinical outcomes.

Midline Catheters:

Midline catheters offer a unique solution for patients requiring intermediate-duration intravenous access. Unlike peripheral catheters, midline catheters can be used for longer periods while still avoiding the complications associated with central venous access. Their use is becoming more prevalent in settings that require extended therapy, such as home healthcare and outpatient infusion centers. The growth of the midline catheter segment is supported by the increasing number of patients requiring prolonged treatments, as well as the rising trend of outpatient care and ambulatory surgical centers. As healthcare systems continue to evolve towards patient-centered care, the adoption of midline catheters is expected to grow significantly.

Peripherally Inserted Central Catheters:

Peripherally inserted central catheters (PICC) are increasingly favored for their versatility and the ability to provide long-term vascular access. These catheters are inserted through a peripheral vein and threaded into the central venous system, making them suitable for patients requiring extended IV therapy, such as those undergoing chemotherapy or long-term antibiotic treatments. The rise in cancer cases and the subsequent increase in chemotherapy treatments are substantial factors driving the demand for PICCs. Additionally, advancements in insertion techniques and catheter designs are enhancing the safety and efficacy of PICCs, further contributing to their market growth. Hospitals are increasingly adopting this modality for its benefits, leading to a promising future for the PICC segment within the intravenous access devices market.

By Application

Administration of Medications:

The administration of medications is one of the primary applications of intravenous access devices. This application necessitates precise and reliable delivery systems, particularly for high-risk medications or those that require strict dosing regimens. The growth in this segment is driven by factors such as the rising incidence of chronic diseases necessitating ongoing treatment and the increasing use of complex biologics, such as monoclonal antibodies and chemotherapy agents. Additionally, the move towards home healthcare is propelling the demand for intravenous medications, as patients prefer receiving treatment in the comfort of their homes. Innovations in medication delivery systems, such as smart pumps and other monitoring technologies, are also boosting the effectiveness and safety of this application in the intravenous access devices market.

Administration of Fluids:

The administration of fluids, including hydration solutions and nutritional support, is a fundamental application of intravenous access devices. This application is particularly crucial in clinical settings where patients may be unable to ingest fluids orally due to surgery, illness, or injury. The increasing incidence of dehydration, particularly among elderly patients and those with chronic conditions, is driving the demand for efficient fluid delivery systems. Furthermore, advancements in intravenous fluid formulations, including electrolyte solutions and total parenteral nutrition, are enhancing patient outcomes and satisfaction. As healthcare providers continue to prioritize patient hydration and nutrition, the administration of fluids through intravenous access devices will remain a pivotal segment of the market.

Blood Transfusion:

Blood transfusion is a critical application of intravenous access devices, especially in surgical settings, trauma cases, and for patients with anemia or blood disorders. The need for safe and effective blood transfusion protocols is paramount, leading to the increasing adoption of specialized intravenous devices designed to facilitate this process. The rise in surgical procedures globally, coupled with an aging population that often requires transfusions, is significantly contributing to the growth of this segment. Moreover, advancements in blood storage and transfusion technologies are improving patient safety and reducing the risk of transfusion-related complications, thereby bolstering the market for intravenous access devices in this application.

Diagnostic Testing:

Diagnostic testing is an essential application of intravenous access devices, particularly in the context of blood draws for laboratory testing. The convenience and efficiency of using intravenous devices for blood sampling are increasingly recognized in clinical practices. The growing emphasis on preventive healthcare and the need for early diagnosis of medical conditions are propelling the demand for intravenous access devices in diagnostic applications. Additionally, advancements in venipuncture techniques and equipment are enhancing the precision and reliability of diagnostic testing, leading to improved patient outcomes. As healthcare systems worldwide continue to prioritize accurate diagnostics, the application of intravenous access devices in this area is expected to witness substantial growth.

By Distribution Channel

Hospitals:

Hospitals represent a significant distribution channel for intravenous access devices, as they are the primary healthcare facilities where such devices are utilized. The high volume of surgical procedures, emergency care, and inpatient treatments necessitates a robust supply of intravenous access devices to ensure effective patient care. The increase in hospital admissions, particularly among elderly patients and those with chronic illnesses, is further driving the demand within this channel. Hospitals are increasingly investing in advanced intravenous access technologies to improve patient outcomes and optimize care delivery, thus reinforcing their position as a key distribution channel for intravenous access devices.

Specialty Clinics:

Specialty clinics, which focus on specific medical fields such as oncology, cardiology, and pain management, are becoming essential distribution channels for intravenous access devices. These clinics often provide specialized treatments that require precise intravenous access, contributing to the growth of this segment. The increasing prevalence of chronic diseases, coupled with advancements in minimally invasive procedures, is driving the demand for intravenous access devices in specialty clinics. As these facilities expand to accommodate a growing patient base, the need for effective and reliable intravenous access systems will continue to increase, solidifying the role of specialty clinics in the intravenous access devices market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction as a distribution channel for intravenous access devices, primarily due to the rise in outpatient surgical procedures. These centers provide patients with the convenience of receiving care without the need for hospital admission, leading to increased demand for intravenous access devices for sedation, pain management, and post-operative care. The growing trend towards outpatient procedures, driven by cost-effectiveness and patient satisfaction, is further propelling the adoption of intravenous devices in ASCs. As the healthcare ecosystem shifts towards more decentralized care models, ambulatory surgical centers are becoming a vital channel for distributing intravenous access devices.

Homecare Settings:

Homecare settings are increasingly recognized as a significant distribution channel for intravenous access devices, driven by the growing trend of home healthcare services. Patients requiring long-term intravenous therapy, such as those undergoing chemotherapy or with chronic diseases, are seeking the comfort and convenience of receiving care at home. This shift is fueled by advancements in medical technology, which have made intravenous devices safer and easier to use outside traditional healthcare settings. The ongoing focus on patient-centered care and cost-effectiveness is also contributing to the growth of this channel, as healthcare providers and patients alike prefer homecare solutions where feasible. As the demand for home healthcare services continues to rise, the role of intravenous access devices in these settings will become ever more critical.

By Material Type

Polyurethane:

Polyurethane is one of the most commonly used materials for intravenous access devices, owing to its excellent biocompatibility, flexibility, and durability. This material is particularly favored for its ability to withstand the rigors of long-term use in various intravenous applications, such as central venous catheters and peripherally inserted central catheters. The growing demand for devices that minimize the risk of thrombosis and infection is driving the adoption of polyurethane-based products. Furthermore, advancements in polyurethane formulations are enhancing the performance and safety of intravenous access devices made from this material, leading to sustained growth in this segment.

Silicon:

Silicon is another widely utilized material in the manufacturing of intravenous access devices, particularly in applications where flexibility and softness are paramount. Silicon catheters are known for their excellent biocompatibility, reducing the risk of irritation and discomfort for patients. The increasing preference for silicon-based products, especially in pediatric and geriatric care, is driving the demand within this material type segment. Moreover, the ease of insertion and longer service life of silicon devices make them a preferred choice for healthcare providers. As the market continues to evolve, the role of silicon in the intravenous access devices landscape is anticipated to grow significantly.

Teflon:

Teflon, known for its low friction properties and inertness, is frequently used in the production of intravenous access devices, particularly peripheral catheters. Teflon catheters are favored for their ease of insertion and reduced risk of phlebitis compared to other materials. The market for Teflon-based intravenous devices is driven by the increasing demand for short-term venous access solutions, particularly in emergency and outpatient settings. As healthcare providers continuously seek ways to improve patient comfort and reduce complications, the use of Teflon in intravenous access devices is expected to remain prominent.

Polyethylene:

Polyethylene is utilized in a range of intravenous access devices, favored for its affordability and versatility. This material is commonly used in the manufacturing of various catheter types, including peripheral and midline catheters. The low cost of polyethylene devices makes them an attractive option for healthcare facilities aiming to manage expenses while still providing quality care. As the healthcare industry increasingly focuses on cost-effectiveness without compromising patient safety, the demand for polyethylene-based intravenous devices is projected to grow. Furthermore, innovations in polyethylene formulations are enhancing the performance characteristics of these devices, ensuring their continued relevance in the market.

By Region

The North American region holds a significant share of the intravenous access devices market, accounting for approximately 40% of the global market in 2022. The presence of advanced healthcare infrastructure, along with high spending on healthcare by both public and private sectors, is driving the demand for intravenous access devices in this region. Moreover, the increasing prevalence of chronic diseases, along with a growing population of elderly individuals, is contributing to the robust growth of the market. The CAGR for North America is projected to be around 6.5% during the forecast period, driven by continual advancements in medical technology and the ongoing emphasis on patient safety and infection control.

In Europe, the intravenous access devices market is expected to experience significant growth, primarily due to the increasing number of surgical procedures and the rising prevalence of chronic diseases. The region is projected to account for approximately 27% of the market share by 2035, with a CAGR of 6.2%. Various initiatives by governments to improve healthcare systems and infrastructure, along with increasing investments in medical devices, are further fostering market growth in Europe. Meanwhile, the Asia Pacific region is anticipated to witness remarkable growth, attributed to the rising population, increasing disposable incomes, and improving healthcare access in emerging economies. The region is expected to contribute around 25% to the global market by 2035, with a CAGR of over 7.0%, indicating a vibrant opportunity for market players.

Opportunities

The intravenous access devices market is poised for remarkable opportunities in the coming years, particularly due to the growing trend of home healthcare services. As more patients prefer receiving medical treatments in their own homes, healthcare providers and manufacturers are focusing on developing portable and user-friendly intravenous access devices. This shift towards home healthcare not only enhances patient comfort and satisfaction but also reduces the overall cost of care. Furthermore, advancements in telemedicine and remote monitoring technologies are expected to complement the use of intravenous access devices at home, creating a synergistic growth environment for this market. The increasing acceptance of these trends by both healthcare providers and patients presents a significant opportunity for innovation and expansion within the intravenous access devices market.

Another promising opportunity lies in the ongoing advancements in medical technology, particularly the development of smart intravenous access devices equipped with monitoring capabilities. These devices can provide real-time data on infusion rates, patient responses, and potential complications, thereby enhancing patient safety and treatment efficacy. The integration of Internet of Things (IoT) technologies into intravenous access devices is also creating new possibilities for data collection and analysis, allowing healthcare professionals to make informed decisions regarding patient care. As the demand for enhanced safety and efficacy in intravenous therapies continues to grow, manufacturers have a unique opportunity to invest in research and development to create next-generation devices that align with these evolving needs.

Threats

Despite the promising outlook for the intravenous access devices market, there are several threats that could potentially impact its growth trajectory. One of the primary threats is the rising prevalence of healthcare-associated infections (HAIs) and complications related to intravenous therapies. These issues can significantly undermine patient safety and lead to increased healthcare costs, resulting in a negative perception of intravenous access devices among healthcare providers and patients. Additionally, regulatory scrutiny and stringent approval processes for new medical devices can pose challenges for manufacturers, particularly smaller companies with limited resources. The potential for product recalls or litigation resulting from safety concerns further adds to the complexity of operating in this market. As healthcare providers continue to prioritize patient safety, manufacturers must address these concerns proactively to maintain their market position.

Moreover, the intravenous access devices market faces significant competition from alternative modes of drug delivery and advancements in non-invasive technologies. As healthcare continues to evolve, patients and providers may gravitate toward less invasive options that minimize complications and enhance comfort. This shift could result in reduced demand for traditional intravenous access devices, particularly in outpatient and home healthcare settings. Additionally, fluctuating economic conditions and budget constraints in healthcare systems around the world may impact the purchasing decisions of healthcare facilities, leading to a potential slowdown in market growth. Manufacturers must remain vigilant and adapt to these changing dynamics to navigate the challenges posed by emerging trends and competitive forces in the industry.

Competitor Outlook

• Becton, Dickinson and Company
• Medtronic plc
• Smiths Medical
• Vygon S.A.S.
• Teleflex Incorporated
• Terumo Corporation
• Boston Scientific Corporation
• Fresenius Kabi AG
• AngioDynamics, Inc.
• Halyard Health, Inc.
• 3M Company
• NIPRO Corporation
• Cardinal Health, Inc.
• Cook Medical, LLC
• GaleMed Corporation

The competitive landscape of the intravenous access devices market is characterized by a mix of established players and emerging companies striving to differentiate their offerings. Leading firms such as Becton, Dickinson and Company and Medtronic plc dominate the market, leveraging their extensive experience in the medical devices sector and broad product portfolios. These companies invest significantly in research and development to innovate and enhance their intravenous access devices, aiming to improve safety and efficacy for healthcare providers and patients alike. Their strong market presence and distribution networks further solidify their positions as key players in this competitive landscape.

In addition to these major players, smaller and emerging companies such as Vygon S.A.S. and AngioDynamics, Inc. are carving out niche markets by offering specialized intravenous access products that cater to specific patient needs. These firms often focus on developing innovative solutions that address the limitations of traditional devices, such as infection control and ease of use. This trend towards specialization is fostering healthy competition in the market, prompting larger companies to take notice and consider strategic partnerships or acquisitions to bolster their product offerings and market reach.

Furthermore, the intravenous access devices market is witnessing an influx of technological advancements, with companies investing in smart devices and digital health solutions. The integration of monitoring technologies and data analytics into intravenous devices is enhancing patient safety and treatment personalization. Companies such as Teleflex Incorporated and Fresenius Kabi AG are at the forefront of these innovations, continuously evolving their product lines to meet the demands of modern healthcare. As the market continues to mature, the emphasis on technological advancements and strategic collaborations will likely shape the competitive dynamics of the intravenous access devices market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon S.A.S.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cook Medical, LLC
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 NIPRO Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 AngioDynamics, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 GaleMed Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Halyard Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cardinal Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Teleflex Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Becton, Dickinson and Company
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Intravenous Access Devices Market, By Application
    • 6.1.1 Administration of Medications
    • 6.1.2 Administration of Fluids
    • 6.1.3 Blood Transfusion
    • 6.1.4 Diagnostic Testing
  • 6.2 Intravenous Access Devices Market, By Product Type
    • 6.2.1 Peripheral Catheters
    • 6.2.2 Central Venous Catheters
    • 6.2.3 Integrated/Closed Catheters
    • 6.2.4 Midline Catheters
    • 6.2.5 Peripherally Inserted Central Catheters
  • 6.3 Intravenous Access Devices Market, By Material Type
    • 6.3.1 Polyurethane
    • 6.3.2 Silicon
    • 6.3.3 Teflon
    • 6.3.4 Polyethylene
  • 6.4 Intravenous Access Devices Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Homecare Settings

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Intravenous Access Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Intravenous Access Devices market is categorized based on

By Product Type

• Peripheral Catheters
• Central Venous Catheters
• Integrated/Closed Catheters
• Midline Catheters
• Peripherally Inserted Central Catheters

By Application

• Administration of Medications
• Administration of Fluids
• Blood Transfusion
• Diagnostic Testing

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings

By Material Type

• Polyurethane
• Silicon
• Teflon
• Polyethylene

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Becton, Dickinson and Company
• Medtronic plc
• Smiths Medical
• Vygon S.A.S.
• Teleflex Incorporated
• Terumo Corporation
• Boston Scientific Corporation
• Fresenius Kabi AG
• AngioDynamics, Inc.
• Halyard Health, Inc.
• 3M Company
• NIPRO Corporation
• Cardinal Health, Inc.
• Cook Medical, LLC
• GaleMed Corporation